The Study on Timolol and Its Potential Phototoxicity Using Chemical, In Silico and In Vitro Methods

• Ngā kaituhi matua: Karolina Lejwoda (Author), Anna Gumieniczek (Author), Agata Filip (Author), Beata Naumczuk (Author)
• Hōputu: Pukapuka
• I whakaputaina: MDPI AG, 2024-01-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Timolol (TIM) is a non-selective ß-adrenergic receptor antagonist used orally for the treatment of hypertension and heart attacks, and topically for treating glaucoma; lately, it has also been used in some specific dermatological problems. In the present study, its photodegradation and potential ris...